Boris Pasche

Boris Pasche currently serves as President and CEO of Karmanos Cancer Institute and Chair of the Department of Oncology at Wayne State University, both positions held since August 2023. As a co-founder of TheraBionic Inc. since March 2007, Boris Pasche has been involved in the development of an FDA-approved device for treating advanced hepatocellular carcinoma. Previously, from March 2014 to August 2023, Boris Pasche was a Professor and Director of the Comprehensive Cancer Center at Atrium Health Wake Forest Baptist. Other notable positions include Associate Editor for the Journal of the American Medical Association, and various academic roles spanning over two decades in esteemed institutions like UAB, Northwestern University, and Memorial Sloan-Kettering Cancer Center. Boris Pasche holds a Doctor of Philosophy in Coagulation Research from Karolinska Institutet and a Doctor of Medicine from the University of Lausanne.